Hyperglycemia and oxidative stress: Complex relationships with attractive prospects

Intensive Care Medicine

Volumn 29, Issue 4, 2003, Pages 511-514

  Leverve, Xavier ^a,b  

^a INSERM   (France)

^b HÔPITAL MICHALLON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; GLUCOSE; REACTIVE OXYGEN METABOLITE;

CRITICAL ILLNESS; EDITORIAL; ENDOCRINE SYSTEM; GLUCOSE HOMEOSTASIS; HYPERGLYCEMIA; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARACRINE SIGNALING;

EID: 0037398012     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-002-1629-3     Document Type: Editorial

References (31)

1. Ross H, Johnston IDA, Wellborn TA, Wright AD (1966) Effect of abdominal operation on glucose tolerance and serum levels of insulin, growth hormone and hydrocortison. Lancet II:563-566
2. Beisel WR (1975) Metabolic response to Infection. Annu Rev Med 26:9-23
3. Goldstein SA, Elwyn DH (1989) The effects of injury and sepsis on fuel utilization. Annu Rev Nutr 9:445-473
4. Fernandez-Real JM, Ricart W (1999) Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness. Diabetologia 42:1367-1374
5. Ruderman NB, Saha AK, Vavvas D, Witters LA (1999) Malonyl-CoA, fuel sensing, and insulin resistance. Am J Physiol 276:E1-E18
6. Alberti KGMM, Batstone GF, Foster KJ, Johnston DG (1980) Relative role of various hormones in mediating the metabolic response to injury. J Parenter Enteral Nutr 4:141-145
7. Cuthbertson D (1932) Observations on the disturbances of metabolism by injury to the limbs. Q J Med 1:233-246
8. Allison SP, Hinton P, Chamberlain MJ (1968) Intravenous glucose-tolerance, insulin, and free-fatty-acid levels in burned patients. Lancet II:1113-1116
9. Hinton P, Allison SP, Littlejohn S, Lloyd J (1971) Insulin and glucose to reduce catabolic response to injury in burned patients. Lancet 1:767-769
10. Wolfe RR (1997) Substrate utilization/insulin resistance in sepsis/trauma. Baillieres Clin Endocrinol Metab 11:645-657
11. Kelley DE, Mandarino LJ (2000) Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49:677-683
12. Kones RJ (1975) Glucose, insulin, and potassium therapy for heart disease. History of GIK therapy. N Y State J Med 75:1463-1492
13. Sievers J, Lindh J, Johansson BW, Karnell J (1966) Acute myocardial infarction treated by glucose-insulin-potassium (GIK) infusion. Cardiology 49:239-247
14. Fath-Ordoubadi F, Beatt KJ (1997) Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation 96:1152-1156
15. Zhu P, Lu L, Xu Y, Greyson C, Schwartz GG (2000) Glucose-insulin-potassium preserves systolic and diastolic function in ischemia and reperfusion in pigs. Am J Physiol Heart Circ Physiol 278:H595-H603
16. Berghe G van den, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359-1367
17. Perner A, Nielsen SE, Rask-Madsen J (2002) High glucose impairs superoxide production from isolated blood neutrophils. Intensive Care Med (http://dx.doi.org/10.1007/s00134-002-1628-4)
18. Wilmore DW, Aulick LH, Mason AD, Pruitt BA (1977) Influence of the burn wound on local and systemic response to injury. Ann Surg 186:444-458
19. Jollier P, Leverve X, Pichard C (2001) Acute hepatic steatosis complicating massive insulin overdose and excessive glucose administration. Intensive Care Med 27:313-316
20. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820
21. Nishikawa T, Edelstein D, Brownlee M (2000) The missing link: a single unifying mechanism for diabetic complications. Kidney Int Suppl 77:S26-S30
22. Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J, Brownlee M (2000) Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci USA 97:12222-12226
23. Asahina T, Kashiwagi A, Nishio Y, Ikebuchi M, Harada N, Tanaka Y, Takagi Y, Saeki Y, Kikkawa R, Shigeta Y (1995) Impaired activation of glucose oxidation and NADPH supply in human endothelial cells exposed to H2O2 in high-glucose medium. Diabetes 44:520-526
24. Zhang Z, Apse K, Pang J, Stanton RC (2000) High glucose inhibits glucose-6-phosphate dehydrogenase via cAMP in aortic endothelial cells. J Biol Chem 275:40042-40047
25. Tsai KJ, Hung IJ, Chow CK, Stern A, Chao SS, Chiu DT (1998) Impaired production of nitric oxide, superoxide, and hydrogen peroxide in glucose 6-phosphate-dehydrogenase-deficient granulocytes. FEBS Lett 436:411-414
26. Spolarics Z, Siddiqi M, Siegel JH, Garcia ZC, Stein DS, Ong H, Livingston DH, Denny T, Deitch EA (2001) Increased incidence of sepsis and altered monocyte functions in severely injured type A-glucose-6-phosphate dehydrogenase-deficient African American trauma patients. Crit Care Med 29:728-736
27. Leopold JA, Cap A, Scribner AW, Stanton RC, Loscalzo J (2001) Glucose-6-phosphate dehydrogenase deficiency promotes endothelial oxidant stress and decreases endothelial nitric oxide bioavailability. FASEB J 15:1771-1773
28. Hashida K, Sakakura Y, Makino N (2002) Kinetic studies on the hydrogen peroxide elimination by cultured PC 12 cells: rate limitation by glucose-6-phosphate dehydrogenase. Biochim Biophys Acta 1572:85-90
29. Kashiwagi A, Asahina T, Nishio Y, Ikebuchi M, Tanaka Y, Kikkawa R, Shigeta Y (1996) Glycation, oxidative stress, and scavenger activity: glucose metabolism and radical scavenger dysfunction in endothelial cells. Diabetes 45 [Suppl 3]:S84-S86
30. Kashiwagi A, Nishio Y, Asahina T, Ikebuchi M, Harada N, Tanaka Y, Takahara N, Taki H, Obata T, Hidaka H, Saeki Y, Kikkawa R (1997) Pyruvate improves deleterious effects of high glucose on activation of pentose phosphate pathway and glutathione redox cycle in endothelial cells. Diabetes 46:2088-2095
31. Lee SM, Koh HJ, Park DC, Song BJ, Huh TL, Park JW (2002) Cytosolic NADP (+)-dependent isocitrate dehydrogenase status modulates oxidative damage to cells. Free Radic Biol Med 32:1185-1196